Displaying results 176 - 200 of 643
Clear search
Bio-Rad extends anti-idiotypic antibody and SpyCatcher Reagent ranges for bioanalysis and antibody drug development
Additions to Company’s Range of Bioanalytical Antibodies and Reagents Enhances Bioanalysis and Antibody-Related Research
Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
AI-enabled analytics platform demonstrates how real-world data used in place of human placebo and control groups can significantly reduce study costs and duration
Mursla Bio introduces AI precision medicine platform built on organ-specific EV isolation from blood
Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samplesEnables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, su
SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers
Recognises the potential of Aurase Wound Gel to improve outcomes for individuals with calciphylaxis ulcers, a rare and life-threatening conditionRepresents a new indication for Aurase Wound Gel, currently in Phase II Clinical Trials for treatment of venous leg ulcers
Kadans Science Partner completes construction of primary structure on purpose built laboratory building at Merlin Place, North Cambridge
Topping out ceremony gathered key stakeholders on Cambridge Wide Open Day to celebrate progress in development of new laboratory facilities139,000 sq ft of flexible lab and office space, due for completion Q3 2026Cambridge, UK, 13 June 2025:
Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy
Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery
Tagomics awarded £860k Innovate UK Biomedical Catalyst grant for detection of colorectal cancer
Grant forms part of £1.2M project to customise Tagomics’ multiomic profiling platform for early detection of colorectal cancerEarly detection test to be developed in collaboration with the Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection biobank
Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional immunotherapy against Gram-negative bacterial infections
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infectionsNovel bifunctional molecule based on Alphamer platform demonstrated direct, broad-spectrum antibacterial activity in vitro and in vivo, with e
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
SB000 reverses cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotencyStudy advances efforts towards next-generation rejuvenation therapeutics with applications across age-driven diseas
Fujifilm rebrands life sciences companies to strengthen position as strategic Partners for Life, offering end-to-end solutions
FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM Biotechnologies, serving global partners seek
Sapio Sciences appoints Gordon McCall as Chief Operating Officer to drive global operational excellence
New role underscores Sapio’s commitment to operational excellence and elevating customer delivery across global markets
Closed Loop Medicine appoints Kate Woolland as CEO
Leadership transition to drive commercialization strategy in deploying and scaling proven platform and therapy-specific precision dosing technologies
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Lord David Prior appointed as Chair of the Board, previously Chairman of NHS England and member of the UK Life Sciences Council Sir Tony Kouzarides, Co-founder and Director, Milner Therapeutics Institute, and Professor of Cancer Biology, Gurdon Institute, appointed as S
Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing
World-class experts from bioprocessing and cell and gene therapy (CGT) fields include Phil Vanek PhD, Carl Schoellhammer PhD, Daniel C.
PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics
Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive DirectorStrategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platform
Trilobio raises $8M to deliver whole lab automation for biologists
San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment.
PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial
Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturingMichele Pedrocchi PhD appointed as Non-Executive Chair of the Board of DirectorsBedfordshire
Sapio Sciences introduces Biorepository Management Solution in Sapio Release 25.4
Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management
Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signallingCompletes unique suite of rapid, scalable pain-related sodium channel assays and services to accelerate hit-to-lead and lead optimisation
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflowEnables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing ap
Mosaic Therapeutics in-licenses two clinical-stage oncology programs from Astex Pharmaceuticals for development as proprietary combination therapies
In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic will develop proprietary, targeted combination products, supported by proprietary biomarkers, to realise the full potential of the assets
Biodesix partner - Friends of Cancer Research, publishes study linking ctDNA changes to solid tumour treatment outcomes
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology
Mursla Bio receives FDA breakthrough device designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients EvoLiver leverages Mursla Bio’s platform based on organ-specific extracellular vesicles circulating in blood Breakthrough status provides